Muna Qayed, MD, MsCR

Research Program

Cancer Immunology
Phone Number

404-785-1200
Email Address

mqayed@emory.edu

Biography

Muna Qayed, MD, MsCR, is a professor in the Department of Pediatrics at Emory University School of Medicine. Dr. Qayed is an attending physician in Pediatric Hematology/Oncology and Bone Marrow Transplantation and medical director of the Cellular Therapy Laboratory at Children's Healthcare of Atlanta.

Dr. Qayed is a member of the Cancer Immunology Research Program at Winship Cancer Institute of Emory University.

Education

Dr. Qayed earned her MD from the University of Jordan. She also holds a Master of Science in Clinical Research from Emory University. After obtaining her medical degree, Dr. Qayed completed a rotating internship at Ministry of Health Hospitals and a pediatric residency at King Hussein Cancer Center, both in Jordan. She then completed another residency in pediatrics at Children's Hospital of Michigan and fellowships in pediatric hematology and oncology and stem cell transplantation at Emory University.

Titles & Roles

Professor, Department of Pediatrics

Emory University School of Medicine
Director, Blood and Marrow Transplant Program

Aflac Cancer and Blood Disorders Center

Professional Memberships

Dr. Qayed is a member of numerous professional organizations including the American Society of Clinical Oncology, American Society of Hematology, American Society for Blood and Marrow Transplantation, Children's Oncology Group, and Pediatric Blood and Marrow Transplant Consortium.

Research

Dr. Qayed's research interests include developing more effective prophylaxis/treatment against graft versus host disease (GVHD) in patients undergoing allogeneic blood and marrow transplant and incorporating biomarkers for early diagnosis. Her current work focuses on establishing an institutional biorepository of bone marrow transplant patient samples linked to clinical data and investigating the use of autologous mesenchymal stromal cells for the treatment of GVHD.

View Current Clinical Trials


A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu... Phase N/A Conditions B-All, Acute Lymphoblastic Leukemia Location Winship Cancer Institute
Pediatric GVHD Low Risk Steroid Taper Trial Phase II Conditions Acute Graft vs Host Disease, Allogeneic Bone Marrow Transplantation, Adverse Effects Location Winship Cancer Institute
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide Phase II Conditions Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Lymphoma Location Winship Cancer Institute
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL Phase II Conditions B-cell Acute Lymphoblastic Leukemia Location Winship Cancer Institute
Rifaximin for Infection Prophylaxis in Hematopoietic Stem Cell Transplantation Phase Early Phase I Conditions Microbial Colonization Location Winship Cancer Institute
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Phase III Conditions PRETEXT I Hepatoblastoma, PRETEXT II Hepatoblastoma, PRETEXT III Hepatoblastoma, PRETEXT IV Hepatoblastoma Location Winship Cancer Institute
CTL019 Phase Expanded Access Location Winship Cancer Institute
Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients Phase II Conditions Non-Hodgkin Lymphoma Location Winship Cancer Institute

Publications

In 2021, Dr. Qayed was inducted to the MilliPub Club, which recognizes current Emory faculty who have published one or more individual papers throughout their careers that have garnered more than 1,000 citations.

Title/Journal	Authors	Publication Date
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis. Blood advances	J Pidala, J Kim, D Kalos, C Cutler, Z DeFilipp, MED Flowers, BK Hamilton, KK Chin, M Rotta, N El Jurdi, M Hamadani, G Ahmed, C Kitko, D Ponce, A Sung, H Tang, N Farhadfar, E Nemecek, I Pusic, M Qayed, H Rangarajan, W Hogan, A Etra, S Jaglowski	03/11/2025
Umbilical Cord Blood Reduced Relapse but Increased Nonrelapse Mortality Compared to Matched Unrelated Donor Transplantation in Pediatric Acute Myeloid Leukemia With Active Disease: A CIBMTR 2008 to 2017 Analysis of Donor Source and Residual Disease. Transplantation and cellular therapy	T Takahashi, F Wachter, F Alvarez Calderon, M Kapadia, M Qayed, AK Keating	02/10/2025
Why are Higher CD34+ Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors - But Not for High-Risk Neuroblastoma? Pediatric hematology and oncology	TE Knight, L Broglie, A Sharma, M Qayed, GA Yanik	02/01/2025
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities. Transplantation and cellular therapy	T Takahashi, B Watkins, B Bratrude, D Neuberg, K Hebert, K Betz, A Yu, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, BR Blazar, JT Horan, A Langston, LS Kean, M Qayed	02/01/2025
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group. Transplantation and cellular therapy	N Katsivelos, N Spyrou, D Weber, I Vasova, F Ayuk, H Choe, W Hogan, Z DeFilipp, M Qayed, AM Etra, K Sandhu, S Kraus, T Olson, E Hexner, P Aguayo-Hiraldo, R Reshef, E Ullrich, T Schechter, C Kitko, C Chanswangphuwana, P Merli, Y Akahoshi, J Baez, G Eng, R Beheshti, S Kowalyk, G Morales, IE Louloudis, R Young, E Holler, R Nakamura, JLM Ferrara, JE Levine	01/01/2025
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes. Transplantation and cellular therapy	SJ Rotz, L Wiener, KS Baker, SW Choi, R Phelan, GDE Cuvelier, C Duncan, KM Williams, M Qayed	12/27/2024
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients. Transplantation and cellular therapy	CAO Rios, M Qayed, AM Etra, R Reshef, R Newcomb, N Yuhasz, EO Hexner, P Aguayo-Hiraldo, P Merli, WJ Hogan, D Weber, CL Kitko, F Ayuk, M Eder, SA Grupp, S Kraus, K Sandhu, E Ullrich, I Vasova, M Wölfl, J Baez, R Beheshti, G Eng, S Gleich, N Katsivelos, S Kowalyk, IE Louloudis, G Morales, N Spyrou, R Young, R Nakamura, JE Levine, JLM Ferrara, Y Akahoshi	11/01/2024
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation. Blood	LS Kean, LJ Burns, TD Kou, R Kapikian, K Lozenski, A Langston, JT Horan, B Watkins, M Qayed, B Bratrude, K Betz, XY Tang, MJ Zhang, SE Connolly, M Polinsky, B Gavin, A Gomez-Caminero, MC Pasquini	10/24/2024
Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children. Transplantation and cellular therapy	ML Schoettler, J Ofori, E Bryson, K Spencer, M Qayed, E Stenger, A Bidgoli, S Chonat, A Westbrook, KM Williams	09/01/2024
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD. Blood	Y Akahoshi, N Spyrou, D Weber, P Aguayo-Hiraldo, F Ayuk, C Chanswangphuwana, HK Choe, M Eder, AM Etra, SA Grupp, EO Hexner, WJ Hogan, CL Kitko, S Kraus, MM Al Malki, P Merli, M Qayed, R Reshef, T Schechter, E Ullrich, I Vasova, M Wölfl, R Zeiser, J Baez, R Beheshti, G Eng, S Gleich, N Katsivelos, S Kowalyk, G Morales, R Young, YB Chen, R Nakamura, JE Levine, JLM Ferrara	08/29/2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD. Blood advances	Z DeFilipp, HT Kim, N Spyrou, N Katsivelos, S Kowalyk, G Eng, S Kasikis, R Beheshti, J Baez, Y Akahoshi, F Ayuk, H Choe, A Etra, SA Grupp, EO Hexner, WJ Hogan, CL Kitko, M Qayed, R Reshef, I Vasova, R Zeiser, R Young, E Holler, JLM Ferrara, R Nakamura, JE Levine, YB Chen	07/09/2024
Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-A secondary CIBMTR analysis. British journal of haematology	ML Schoettler, A Westbrook, B Watkins, E Stenger, M Qayed, S Chonat, KM Williams	07/01/2024
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation. Nature medicine	MS Zinter, CC Dvorak, MY Mayday, G Reyes, MR Simon, EM Pearce, H Kim, PJ Shaw, CM Rowan, JJ Auletta, PL Martin, K Godder, CN Duncan, NR Lalefar, EM Kreml, JR Hume, H Abdel-Azim, C Hurley, GDE Cuvelier, AK Keating, M Qayed, JS Killinger, JC Fitzgerald, R Hanna, KM Mahadeo, TC Quigg, P Satwani, P Castillo, SJ Gertz, TB Moore, B Hanisch, A Abdel-Mageed, R Phelan, DB Davis, MP Hudspeth, GA Yanik, MA Pulsipher, I Sulaiman, LN Segal, BA Versluys, CA Lindemans, JJ Boelens, JL DeRisi	07/01/2024
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD. Blood advances	A Etra, N El Jurdi, N Katsivelos, D Kwon, S Gergoudis, G Morales, N Spyrou, S Kowalyk, P Aguayo-Hiraldo, Y Akahoshi, F Ayuk, J Baez, BC Betts, C Chanswangphuwana, YB Chen, H Choe, Z DeFilipp, S Gleich, E Hexner, WJ Hogan, E Holler, CL Kitko, S Kraus, M Al Malki, M MacMillan, A Pawarode, F Quagliarella, M Qayed, R Reshef, T Schechter, I Vasova, D Weisdorf, M Wölfl, R Young, R Nakamura, JLM Ferrara, JE Levine, S Holtan	06/25/2024
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD. Transplantation and cellular therapy	M Qayed, U Kapoor, S Gillespie, A Westbrook, P Aguayo-Hiraldo, FA Ayuk, M Aziz, J Baez, H Choe, Z DeFilipp, A Etra, SA Grupp, E Hexner, E Holler, WJ Hogan, S Kowalyk, P Merli, G Morales, R Nakamura, MA Pulsipher, T Schechter, J Shah, N Spyrou, HK Srinagesh, M Wölfl, G Yanik, R Young, CL Kitko, JLM Ferrara, JE Levine	06/01/2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD. Bone marrow transplantation	L Gorfinkel, S Raghunandan, B Watkins, K Hebert, DS Neuberg, B Bratrude, K Betz, A Yu, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, BR Blazar, JT Horan, A Langston, LS Kean, M Qayed	05/01/2024
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. Blood advances	Y Akahoshi, N Spyrou, M Hoepting, P Aguayo-Hiraldo, F Ayuk, C Chanswangphuwana, HK Choe, M Eder, AM Etra, SA Grupp, EO Hexner, WJ Hogan, CL Kitko, S Kraus, MM Al Malki, P Merli, M Qayed, R Reshef, T Schechter, E Ullrich, I Vasova, M Wölfl, R Zeiser, J Baez, R Beheshti, G Eng, S Gleich, S Kasikis, N Katsivelos, S Kowalyk, G Morales, R Young, Z DeFilipp, JLM Ferrara, JE Levine, R Nakamura	04/23/2024
A Day 14 Endpoint for Acute GVHD Clinical Trials. Transplantation and cellular therapy	N Spyrou, Y Akahoshi, S Kowalyk, G Morales, R Beheshti, P Aguayo-Hiraldo, MM Al Malki, F Ayuk, P Bader, J Baez, A Capellini, H Choe, Z DeFilipp, M Eder, G Eng, A Etra, S Gleich, SA Grupp, E Hexner, M Hoepting, WJ Hogan, S Kasikis, N Katsivelos, A Khan, CL Kitko, S Kraus, D Kwon, P Merli, J Portelli, M Qayed, R Reshef, T Schechter, I Vasova, M Wölfl, K Wudhikarn, R Young, E Holler, YB Chen, R Nakamura, JE Levine, JLM Ferrara	04/01/2024
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication. Nature communications	MD Keller, SA Schattgen, S Chandrakasan, EK Allen, MA Jensen-Wachspress, CA Lazarski, M Qayed, H Lang, PJ Hanley, J Tanna, SY Pai, S Parikh, SI Berger, S Gottschalk, MA Pulsipher, PG Thomas, CM Bollard	03/29/2024
D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study. American journal of hematology	ML Schoettler, K French, A Harris, E Bryson, L Deeb, Z Hudson, J Obordo, S Chandrakasan, S Parikh, B Watkins, E Stenger, M Qayed, S Chonat, A Westbrook, J Switchenko, KM Williams	03/01/2024
Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children. Transplantation and cellular therapy	ML Schoettler, S Patel, E Bryson, L Deeb, B Watkins, M Qayed, S Chandrakasan, T Fitch, K Silvis, J Jones, S Chonat, KM Williams	03/01/2024
Novel approaches to acute graft-versus-host disease prevention. Hematology. American Society of Hematology. Education Program	B Watkins, M Qayed	12/08/2023
No impact of CD34⁺ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma. Bone marrow transplantation	TE Knight, KW Ahn, KM Hebert, R Atshan, DA Wall, K Chiengthong, TC Lund, T Prestidge, HG Rangarajan, CC Dvorak, JJ Auletta, M Kent, H Hashem, JA Talano, SJ Rotz, E Fraint, KC Myers, W Leung, A Sharma, NS Bhatt, TA Driscoll, LC Yu, KR Schultz, M Qayed, L Broglie, M Eapen, GA Yanik	12/01/2023
Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplantation and cellular therapy	PA Patel, MF Teherani, Y Xiang, V Bernardo, S Chandrakasan, KP Goggin, A Haight, E Horwitz, WH Liang, SH Parikh, ML Schoettler, K Spencer, E Stenger, B Watkins, KM Williams, K Leung, P Jaggi, M Qayed	12/01/2023
Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patients. medRxiv : the preprint server for health sciences	MS Zinter, CC Dvorak, MY Mayday, G Reyes, MR Simon, EM Pearce, H Kim, PJ Shaw, CM Rowan, JJ Auletta, PL Martin, K Godder, CN Duncan, NR Lalefar, EM Kreml, JR Hume, H Abdel-Azim, C Hurley, GDE Cuvelier, AK Keating, M Qayed, JS Killinger, JC Fitzgerald, R Hanna, KM Mahadeo, TC Quigg, P Satwani, P Castillo, SJ Gertz, TB Moore, B Hanisch, A Abdel-Mageed, R Phelan, DB Davis, MP Hudspeth, GA Yanik, MA Pulsipher, I Sulaiman, LN Segal, BA Versluys, CA Lindemans, JJ Boelens, JL DeRisi	11/29/2023
Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies. Bone marrow transplantation	S Raghunandan, M Qayed, BK Watkins, M Graiser, L Gorfinkel, A Westbrook, S Gillespie, B Bratrude, A Petrovic, Y Suessmuth, J Horan, LS Kean, AA Langston	11/01/2023
Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis. Bone marrow transplantation	S Raghunandan, L Gorfinkel, B Bratrude, Y Suessmuth, K Hebert, D Neuberg, KM Williams, ML Schoettler, AA Langston, LS Kean, M Qayed, J Horan, BK Watkins	11/01/2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns. EClinicalMedicine	V Barsan, Y Li, S Prabhu, C Baggott, K Nguyen, H Pacenta, CL Phillips, J Rossoff, H Stefanski, JA Talano, A Moskop, S Baumeister, MR Verneris, GD Myers, NA Karras, S Cooper, M Qayed, M Hermiston, P Satwani, C Krupski, A Keating, V Fabrizio, V Chinnabhandar, M Kunicki, KJ Curran, CL Mackall, TW Laetsch, LM Schultz	11/01/2023
Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor-Case report and review of the literature. Pediatric blood & cancer	C Hughes, A Harris, B Watkins, M Qayed, S Parikh, E Horwitz, E Stenger, KM Williams, ML Schoettler	10/01/2023
The utility of biomarkers in acute GVHD prognostication. Blood advances	N Spyrou, Y Akahoshi, F Ayuk, E Holler, H Choe, A Etra, WJ Hogan, W Rösler, E Hexner, Z DeFilipp, R Reshef, C Chanswangphuwana, M Qayed, S Kraus, M Eder, NR Javorniczky, SA Grupp, CL Kitko, P Merli, P Aguayo-Hiraldo, M Wölfl, J Baez, R Beheshti, G Eng, S Gleich, N Katsivelos, A Khan, S Kowalyk, G Morales, R Young, R Nakamura, YB Chen, JE Levine, JLM Ferrara	09/12/2023
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events. Blood	T Takahashi, M Al-Kofahi, M Jaber, B Bratrude, K Betz, Y Suessmuth, A Yu, DS Neuberg, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, BR Blazar, JT Horan, B Watkins, A Langston, M Qayed, LS Kean	08/24/2023
Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis. Blood advances	S Raghunandan, L Gorfinkel, M Graiser, B Bratrude, Y Suessmuth, S Gillespie, AL Westbrook, KM Williams, ML Schoettler, LS Kean, J Horan, AA Langston, M Qayed, B Watkins	08/22/2023
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD. Blood advances	Y Akahoshi, N Spyrou, WJ Hogan, F Ayuk, Z DeFilipp, D Weber, HK Choe, EO Hexner, W Rösler, AM Etra, K Sandhu, GA Yanik, C Chanswangphuwana, CL Kitko, R Reshef, S Kraus, M Wölfl, M Eder, H Bertrand, M Qayed, P Merli, SA Grupp, P Aguayo-Hiraldo, T Schechter, E Ullrich, J Baez, R Beheshti, S Gleich, S Kowalyk, G Morales, R Young, D Kwon, R Nakamura, JE Levine, JLM Ferrara, YB Chen	08/22/2023
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL. Blood advances	KO McNerney, SJ Si Lim, K Ishikawa, A Dreyzin, A Vatsayan, JJ Chen, C Baggott, S Prabhu, HL Pacenta, C Philips, J Rossoff, HE Stefanski, JA Talano, A Moskop, M Verneris, D Myers, NA Karras, P Brown, CL Bonifant, M Qayed, M Hermiston, P Satwani, C Krupski, AK Keating, SHC Baumeister, VA Fabrizio, V Chinnabhandar, E Egeler, S Mavroukakis, KJ Curran, CL Mackall, TW Laetsch, LM Schultz	06/27/2023
Effect of Autograft CD34⁺ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors. Transplantation and cellular therapy	TE Knight, KW Ahn, KM Hebert, R Atshan, DA Wall, K Chiengthong, SJ Rotz, E Fraint, HG Rangarajan, JJ Auletta, A Sharma, CL Kitko, H Hashem, KM Williams, B Wirk, CC Dvorak, KC Myers, MA Pulsipher, AB Warwick, NR Lalefar, KR Schultz, M Qayed, L Broglie, M Eapen, GA Yanik	06/01/2023
Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure. Blood advances	EO Stenger, B Watkins, K Rogowski, KY Chiang, A Haight, K Leung, M Qayed, S Raghunandan, Y Suessmuth, L Kean, J Horan	05/23/2023
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children. Blood advances	M Schoettler, E Stenger, K Spencer, D Lutterman, S Rumbika, J Jones, A Haight, S Parikh, M Qayed, B Watkins, L Krishnamurti, KM Williams, S Chonat	05/09/2023
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma. Journal for immunotherapy of cancer	S Raghunandan, M Pauly, WG Blum, M Qayed, MV Dhodapkar, M Elkhalifa, B Watkins, M Schoettler, E Horwitz, S Parikh, S Chandrakasan, K Leung, E Bryson, L Deeb, JL Kaufman, D Worthington-White, A Alazraki, JM Schecter, D Madduri, CC Jackson, E Zudaire, A Taraseviciute-Morris, A Babich, T Nesheiwat, M Vogel, N Lendvai, L Pacaud, KM Williams	05/01/2023
Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice Guidelines. Transplantation and cellular therapy	E Fraint, H Abdel-Azim, NS Bhatt, L Broglie, A Chattha, M Kohorst, YP Ktena, MA Lee, S Long, M Qayed, A Sharma, H Stefanski, A Vatsayan, L Wray, M Hamadani, PA Carpenter	05/01/2023
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	TW Laetsch, SL Maude, S Rives, H Hiramatsu, H Bittencourt, P Bader, A Baruchel, M Boyer, B De Moerloose, M Qayed, J Buechner, MA Pulsipher, GD Myers, HE Stefanski, PL Martin, E Nemecek, C Peters, G Yanik, SL Khaw, KL Davis, J Krueger, A Balduzzi, N Boissel, R Tiwari, D O'Donovan, SA Grupp	03/20/2023
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium. Blood advances	HE Stefanski, A Eaton, C Baggott, J Rossoff, MR Verneris, S Prabhu, HL Pacenta, CL Phillips, JA Talano, A Moskop, SP Margossian, GD Myers, NA Karras, PA Brown, M Qayed, M Hermiston, P Satwani, MC Krupski, AK Keating, R Wilcox, CA Rabik, VA Fabrizio, V Chinnabhandar, AY Goksenin, KJ Curran, CL Mackall, TW Laetsch, LM Schultz	02/28/2023
Effective treatment of low-risk acute GVHD with itacitinib monotherapy. Blood	A Etra, A Capellini, A Alousi, MM Al Malki, H Choe, Z DeFilipp, WJ Hogan, CL Kitko, F Ayuk, J Baez, I Gandhi, S Kasikis, S Gleich, E Hexner, M Hoepting, U Kapoor, S Kowalyk, D Kwon, A Langston, M Mielcarek, G Morales, U Özbek, M Qayed, R Reshef, W Rösler, N Spyrou, R Young, YB Chen, JLM Ferrara, JE Levine	02/02/2023
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	LM Schultz, A Eaton, C Baggott, J Rossoff, S Prabhu, AK Keating, C Krupski, H Pacenta, CL Philips, JA Talano, A Moskop, SHC Baumeister, GD Myers, NA Karras, PA Brown, M Qayed, M Hermiston, P Satwani, R Wilcox, CA Rabik, VA Fabrizio, V Chinnabhandar, M Kunicki, S Mavroukakis, E Egeler, Y Li, CL Mackall, KJ Curran, MR Verneris, TW Laetsch, H Stefanski	01/10/2023
Diffuse alveolar hemorrhage after hematopoietic cell transplantation- response to treatments and risk factors for mortality. Frontiers in oncology	ML Schoettler, CE Dandoy, A Harris, M Chan, KM Tarquinio, S Jodele, M Qayed, B Watkins, P Kamat, T Petrillo, J Obordo, CS Higham, CC Dvorak, A Westbrook, MS Zinter, KM Williams	01/01/2023
Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing. Cytotherapy	M Qayed, JP McGuirk, GD Myers, V Parameswaran, EK Waller, P Holman, M Rodrigues, LF Clough, J Willert	09/01/2022
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia. Blood advances	A Moskop, L Pommert, C Baggott, S Prabhu, HL Pacenta, CL Phillips, J Rossoff, HE Stefanski, JA Talano, SP Margossian, MR Verneris, GD Myers, NA Karras, PA Brown, M Qayed, ML Hermiston, P Satwani, C Krupski, AK Keating, R Wilcox, CA Rabik, VA Fabrizio, V Chinnabhandar, AY Goksenin, KJ Curran, CL Mackall, TW Laetsch, EM Guest, EH Breese, LM Schultz	07/26/2022
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification. Blood advances	A Etra, S Gergoudis, G Morales, N Spyrou, J Shah, S Kowalyk, F Ayuk, J Baez, C Chanswangphuwana, YB Chen, H Choe, Z DeFilipp, I Gandhi, E Hexner, WJ Hogan, E Holler, U Kapoor, CL Kitko, S Kraus, JY Lin, M Al Malki, P Merli, A Pawarode, MA Pulsipher, M Qayed, R Reshef, W Rösler, T Schechter, G Van Hyfte, D Weber, M Wölfl, R Young, U Özbek, JLM Ferrara, JE Levine	06/28/2022
Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia. Leukemia	TW Laetsch, SL Maude, A Balduzzi, S Rives, H Bittencourt, MW Boyer, J Buechner, B De Moerloose, M Qayed, CL Phillips, MA Pulsipher, H Hiramatsu, R Tiwari, SA Grupp	06/01/2022
Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation. Blood advances	S Janardan, E Horwitz, B Watkins, K Williams, S Chandrakasan, M Qayed, S Parikh, S Arnold, F Keller, A Alazraki, M Schoettler, K Leung	05/24/2022
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood advances	VA Fabrizio, JJ Boelens, A Mauguen, C Baggott, S Prabhu, E Egeler, S Mavroukakis, H Pacenta, CL Phillips, J Rossoff, HE Stefanski, JA Talano, A Moskop, SP Margossian, MR Verneris, GD Myers, NA Karras, PA Brown, M Qayed, M Hermiston, P Satwani, C Krupski, AK Keating, R Wilcox, CA Rabik, V Chinnabhandar, M Kunicki, AY Goksenin, CL Mackall, TW Laetsch, LM Schultz, KJ Curran	04/12/2022
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	LM Schultz, C Baggott, S Prabhu, HL Pacenta, CL Phillips, J Rossoff, HE Stefanski, JA Talano, A Moskop, SP Margossian, MR Verneris, GD Myers, NA Karras, PA Brown, M Qayed, M Hermiston, P Satwani, C Krupski, AK Keating, R Wilcox, CA Rabik, VA Fabrizio, RH Rouce, V Chinnabhandar, M Kunicki, VV Barsan, AY Goksenin, Y Li, S Mavroukakis, E Egeler, KJ Curran, CL Mackall, TW Laetsch	03/20/2022
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation. Blood advances	M Qayed, B Watkins, S Gillespie, B Bratrude, K Betz, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, M Norkin, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, EK Waller, A Langston, LS Kean, JT Horan	02/08/2022
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report. Blood advances	VA Fabrizio, CL Phillips, A Lane, C Baggott, S Prabhu, E Egeler, S Mavroukakis, H Pacenta, J Rossoff, HE Stefanski, JA Talano, A Moskop, SP Margossian, MR Verneris, GD Myers, NA Karras, PA Brown, M Qayed, M Hermiston, P Satwani, C Krupski, AK Keating, R Wilcox, CA Rabik, V Chinnabhandar, M Kunicki, AY Goksenin, KJ Curran, CL Mackall, TW Laetsch, LM Schultz	01/25/2022
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia. Blood cancer discovery	MA Pulsipher, X Han, SL Maude, TW Laetsch, M Qayed, S Rives, MW Boyer, H Hiramatsu, GA Yanik, T Driscoll, GD Myers, P Bader, A Baruchel, J Buechner, HE Stefanski, C Kalfoglou, K Nguyen, ER Waldron, K Thudium Mueller, HJ Maier, G Kari, SA Grupp	01/01/2022
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease. Frontiers in immunology	E Stenger, CR Giver, A Langston, D Kota, PK Das, R Chinnadurai, J Galipeau, EK Waller, M Qayed	01/01/2022
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease. Transplantation and cellular therapy	MG Zewde, G Morales, I Gandhi, U Özbek, P Aguayo-Hiraldo, F Ayuk, J Baez, C Chanswangphuwana, H Choe, Z DeFilipp, A Etra, S Grupp, EO Hexner, W Hogan, NR Javorniczky, S Kasikis, CL Kitko, S Kowalyk, E Meedt, P Merli, R Nakamura, M Qayed, R Reshef, W Rösler, T Schechter, D Weber, M Wölfl, G Yanik, R Young, JE Levine, JLM Ferrara, YB Chen	12/01/2021
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia. Blood	J Rossoff, C Baggott, S Prabhu, H Pacenta, CL Phillips, H Stefanski, JA Talano, A Moskop, SP Margossian, MR Verneris, GD Myers, N Karras, PA Brown, M Qayed, M Hermiston, P Satwani, C Krupski, AK Keating, R Wilcox, CA Rabik, VA Fabrizio, M Kunicki, V Chinnabhandar, AY Goksenin, KJ Curran, CL Mackall, TW Laetsch, LM Schultz	11/25/2021
Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers. Bone marrow transplantation	S Kasikis, J Baez, I Gandhi, S Grupp, CL Kitko, S Kowalyk, P Merli, G Morales, MA Pulsipher, M Qayed, M Wölfl, G Yanik, F See, J Hayes, F Grossman, E Burke, R Young, JE Levine, JLM Ferrara	11/01/2021
Role of chimeric antigen receptor T-cell therapy: bridge to transplantation or stand-alone therapy in pediatric acute lymphoblastic leukemia. Current opinion in hematology	M Qayed, M Bleakley, NN Shah	11/01/2021
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia. Journal for immunotherapy of cancer	JE Levine, SA Grupp, MA Pulsipher, AC Dietz, S Rives, GD Myers, KJ August, MR Verneris, J Buechner, TW Laetsch, H Bittencourt, A Baruchel, MW Boyer, B De Moerloose, M Qayed, SM Davies, CL Phillips, TA Driscoll, P Bader, K Schlis, PA Wood, R Mody, L Yi, M Leung, LK Eldjerou, CH June, SL Maude	08/01/2021
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	B Watkins, M Qayed, C McCracken, B Bratrude, K Betz, Y Suessmuth, A Yu, S Sinclair, S Furlan, S Bosinger, V Tkachev, J Rhodes, AG Tumlin, A Narayan, K Cribbin, S Gillespie, TA Gooley, MC Pasquini, K Hebert, U Kapoor, A Rogatko, M Tighiouart, S Kim, C Bresee, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, M Norkin, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, EK Waller, JE Levine, JL Ferrara, BR Blazar, A Langston, JT Horan, LS Kean	06/10/2021
Indole derivatives, microbiome and graft versus host disease. Current opinion in immunology	M Qayed, D Michonneau, G Socié, EK Waller	06/01/2021
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation. Blood	M Qayed, KW Ahn, CL Kitko, MH Johnson, NN Shah, C Dvorak, K Mellgren, BD Friend, MR Verneris, W Leung, J Toporski, J Levine, J Chewning, A Wayne, U Kapoor, B Triplett, KR Schultz, GA Yanik, M Eapen	02/18/2021
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8⁺ T cells drive gastrointestinal acute graft-versus-host disease. Science translational medicine	V Tkachev, J Kaminski, EL Potter, SN Furlan, A Yu, DJ Hunt, C McGuckin, H Zheng, L Colonna, U Gerdemann, J Carlson, M Hoffman, J Olvera, C English, A Baldessari, A Panoskaltsis-Mortari, B Watkins, M Qayed, Y Suessmuth, K Betz, B Bratrude, A Langston, JT Horan, J Ordovas-Montanes, AK Shalek, BR Blazar, M Roederer, LS Kean	01/13/2021
Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia. Frontiers in pediatrics	M Wölfl, M Qayed, MI Benitez Carabante, T Sykora, H Bonig, A Lawitschka, C Diaz-de-Heredia	01/01/2021
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	A Im, A Rashidi, T Wang, M Hemmer, ML MacMillan, J Pidala, M Jagasia, S Pavletic, NS Majhail, D Weisdorf, H Abdel-Azim, V Agrawal, AS Al-Homsi, M Aljurf, M Askar, JJ Auletta, A Bashey, A Beitinjaneh, VR Bhatt, M Byrne, JY Cahn, M Cairo, P Castillo, J Cerny, S Chhabra, H Choe, S Ciurea, A Daly, MAD Perez, N Farhadfar, SM Gadalla, R Gale, S Ganguly, U Gergis, R Hanna, P Hematti, R Herzig, GC Hildebrandt, DP Lad, C Lee, L Lehmann, L Lekakis, RT Kamble, MA Kharfan-Dabaja, P Khandelwal, R Martino, HS Murthy, T Nishihori, TA O'Brien, RF Olsson, SS Patel, MA Perales, T Prestidge, M Qayed, R Romee, H Schoemans, S Seo, A Sharma, M Solh, R Strair, T Teshima, A Urbano-Ispizua, M Van der Poel, R Vij, JL Wagner, B William, B Wirk, JA Yared, SR Spellman, M Arora, BK Hamilton	08/01/2020
Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant. Leukemia	MD Aziz, J Shah, U Kapoor, C Dimopoulos, S Anand, A Augustine, F Ayuk, M Chaudhry, YB Chen, HK Choe, A Etra, S Gergoudis, MJ Hartwell, EO Hexner, WJ Hogan, CL Kitko, S Kowalyk, N Kröger, P Merli, G Morales, R Nakamura, R Ordemann, MA Pulsipher, M Qayed, R Reshef, W Rösler, T Schechter, E Schreiner, H Srinagesh, M Wölfl, K Wudhikarn, G Yanik, R Young, U Özbek, JLM Ferrara, JE Levine	07/01/2020
Routine Surveillance Imaging Is Associated with Improved Postrelapse Survival in Patients with Ewing Sarcoma. Journal of adolescent and young adult oncology	T Cash, EL Bettermann, S Mitchell, C McCracken, M Qayed, D Wolfe, A Alazraki, TA Olson, HM Katzenstein	06/01/2020
Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease. British journal of haematology	RS Nickel, JT Horan, A Abraham, M Qayed, A Haight, A Ngwube, H Liang, NLC Luban, JE Hendrickson	04/01/2020
A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors. Pediatric blood & cancer	M Qayed, T Cash, M Tighiouart, TJ MacDonald, KC Goldsmith, R Tanos, L Kean, B Watkins, Y Suessmuth, C Wetmore, HM Katzenstein	04/01/2020
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease. Blood advances	HK Srinagesh, U Özbek, U Kapoor, F Ayuk, M Aziz, K Ben-David, HK Choe, Z DeFilipp, A Etra, SA Grupp, MJ Hartwell, EO Hexner, WJ Hogan, AB Karol, S Kasikis, CL Kitko, S Kowalyk, JY Lin, H Major-Monfried, S Mielke, P Merli, G Morales, R Ordemann, MA Pulsipher, M Qayed, P Reddy, R Reshef, W Rösler, KS Sandhu, T Schechter, J Shah, K Sigel, D Weber, M Wölfl, K Wudhikarn, R Young, JE Levine, JLM Ferrara	12/10/2019
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	A Saad, L Lamb, T Wang, MT Hemmer, S Spellman, D Couriel, A Alousi, J Pidala, H Abdel-Azim, V Agrawal, M Aljurf, AM Beitinjaneh, VR Bhatt, D Buchbinder, M Byrne, JY Cahn, M Cairo, P Castillo, S Chhabra, MA Diaz, S Farhan, Y Floisand, HA Frangoul, SM Gadalla, J Gajewski, RP Gale, M Gandhi, U Gergis, BK Hamilton, P Hematti, GC Hildebrandt, RT Kamble, AS Kanate, P Khandelwal, A Lazaryan, M MacMillan, DI Marks, R Martino, PA Mehta, T Nishihori, RF Olsson, SS Patel, M Qayed, HG Rangarajan, R Reshef, O Ringden, BN Savani, HC Schouten, KR Schultz, S Seo, BC Shaffer, M Solh, T Teshima, A Urbano-Ispizua, LF Verdonck, R Vij, EK Waller, B William, B Wirk, JA Yared, LC Yu, M Arora, S Hashmi	09/01/2019
Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	D Kilari, A D'Souza, R Fraser, M Qayed, O Davila, V Agrawal, MA Diaz, S Chhabra, J Cerny, E Copelan, N Farhadfar, CO Freytes, RP Gale, S Ganguly, GC Hildebrandt, L Holmberg, RT Kamble, P Kapoor, H Lazarus, C Lee, HS Murthy, S Naik, T Nishihori, A Saad, BN Savani, S Seo, A Warwick, B Wirk, JA Yared, Y Nieto, P Hari	06/01/2019
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. Blood advances	RS Mehta, SG Holtan, T Wang, MT Hemmer, SR Spellman, M Arora, DR Couriel, AM Alousi, J Pidala, H Abdel-Azim, I Ahmed, M Aljurf, M Askar, JJ Auletta, V Bhatt, C Bredeson, S Chhabra, S Gadalla, J Gajewski, RP Gale, U Gergis, P Hematti, GC Hildebrandt, Y Inamoto, C Kitko, P Khandelwal, ML MacMillan, N Majhail, DI Marks, P Mehta, T Nishihori, RF Olsson, A Pawarode, MA Diaz, T Prestidge, M Qayed, H Rangarajan, O Ringden, A Saad, BN Savani, S Seo, A Shah, N Shah, KR Schultz, M Solh, T Spitzer, J Szer, T Teshima, LF Verdonck, KM Williams, B Wirk, J Wagner, JA Yared, DJ Weisdorf	05/14/2019
Evaluating approaches to enhance survival in children with hypodiploid acute lymphoblastic leukaemia (ALL). British journal of haematology	L Miller, S Kobayashi, M Pauly, G Lew, D Saxe, F Keller, M Qayed, S Castellino	05/01/2019
Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial. The Lancet. Oncology	HM Katzenstein, MR Langham, MH Malogolowkin, MD Krailo, AJ Towbin, MB McCarville, MJ Finegold, S Ranganathan, S Dunn, ED McGahren, GM Tiao, AF O'Neill, M Qayed, WL Furman, C Xia, C Rodriguez-Galindo, RL Meyers	05/01/2019
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	S Chhabra, Y Liu, MT Hemmer, L Costa, JA Pidala, DR Couriel, AM Alousi, NS Majhail, RK Stuart, D Kim, O Ringden, A Urbano-Ispizua, A Saad, BN Savani, B Cooper, DI Marks, G Socie, HC Schouten, H Schoemans, H Abdel-Azim, J Yared, JY Cahn, J Wagner, JH Antin, LF Verdonck, L Lehmann, MD Aljurf, ML MacMillan, MR Litzow, MM Solh, M Qayed, P Hematti, RT Kamble, R Vij, RJ Hayashi, RP Gale, R Martino, S Seo, SK Hashmi, T Nishihori, T Teshima, U Gergis, Y Inamoto, SR Spellman, M Arora, BK Hamilton	01/01/2019
Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease. Blood	A Swimm, CR Giver, Z DeFilipp, S Rangaraju, A Sharma, A Ulezko Antonova, R Sonowal, C Capaldo, D Powell, M Qayed, D Kalman, EK Waller	12/06/2018
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia. Nature medicine	EJ Orlando, X Han, C Tribouley, PA Wood, RJ Leary, M Riester, JE Levine, M Qayed, SA Grupp, M Boyer, B De Moerloose, ER Nemecek, H Bittencourt, H Hiramatsu, J Buechner, SM Davies, MR Verneris, K Nguyen, JL Brogdon, H Bitter, M Morrissey, P Pierog, S Pantano, JA Engelman, W Winckler	10/01/2018
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD. Blood	H Major-Monfried, AS Renteria, A Pawarode, P Reddy, F Ayuk, E Holler, YA Efebera, WJ Hogan, M Wölfl, M Qayed, EO Hexner, K Wudhikarn, R Ordemann, R Young, J Shah, MJ Hartwell, MS Chaudhry, M Aziz, A Etra, GA Yanik, N Kröger, D Weber, YB Chen, R Nakamura, W Rösler, CL Kitko, AC Harris, M Pulsipher, R Reshef, S Kowalyk, G Morales, I Torres, U Özbek, JLM Ferrara, JE Levine	06/21/2018
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants. Blood advances	AJ Kumar, S Kim, MT Hemmer, M Arora, SR Spellman, JA Pidala, DR Couriel, AM Alousi, MD Aljurf, JY Cahn, MS Cairo, CS Cutler, S Farhan, U Gergis, GA Hale, SK Hashmi, Y Inamoto, RT Kamble, MA Kharfan-Dabaja, ML MacMillan, DI Marks, H Nakasone, M Norkin, M Qayed, O Ringden, HC Schouten, KR Schultz, MM Solh, T Teshima, A Urbano-Ispizua, LF Verdonck, RP Gale, BK Hamilton, NS Majhail, AW Loren	05/08/2018
Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	M Qayed, T Wang, MT Hemmer, S Spellman, M Arora, D Couriel, A Alousi, J Pidala, H Abdel-Azim, M Aljurf, M Ayas, M Bitan, M Cairo, SW Choi, C Dandoy, D Delgado, RP Gale, G Hale, H Frangoul, RT Kamble, M Kharfan-Dabaja, L Lehman, J Levine, M MacMillan, DI Marks, T Nishihori, RF Olsson, P Hematti, O Ringden, A Saad, P Satwani, BN Savani, KR Schultz, S Seo, S Shenoy, EK Waller, L Yu, MM Horowitz, J Horan	03/01/2018
Infusion hemolysis after pediatric major ABO-mismatched bone marrow transplant: Comparison of two red blood cell depletion techniques. Pediatric blood & cancer	RS Nickel, M Qayed, D Worthington-White, SR Stowell, KY Chiang	03/01/2018
Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach. Cell reports	R Chinnadurai, D Rajan, M Qayed, D Arafat, M Garcia, Y Liu, S Kugathasan, LJ Anderson, G Gibson, J Galipeau	02/27/2018
Early blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III-IV GVHD in children and adolescents. Pediatric blood & cancer	H Sano, JA Hilinski, M Qayed, K Applegate, JG Newton, B Watkins, KY Chiang, J Horan	02/01/2018
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. The New England journal of medicine	SL Maude, TW Laetsch, J Buechner, S Rives, M Boyer, H Bittencourt, P Bader, MR Verneris, HE Stefanski, GD Myers, M Qayed, B De Moerloose, H Hiramatsu, K Schlis, KL Davis, PL Martin, ER Nemecek, GA Yanik, C Peters, A Baruchel, N Boissel, F Mechinaud, A Balduzzi, J Krueger, CH June, BL Levine, P Wood, T Taran, M Leung, KT Mueller, Y Zhang, K Sen, D Lebwohl, MA Pulsipher, SA Grupp	02/01/2018
Respiratory Difficulties in Children With Underlying Asthma During Immunotherapy for High-risk Neuroblastoma. Journal of pediatric hematology/oncology	LK Metrock, M Qayed, D Simon, T Cash, MG O'Connor, S Johnson, N Esiashvili, HM Katzenstein	11/01/2017
Building blocks for institutional preparation of CTL019 delivery. Cytotherapy	J McGuirk, EK Waller, M Qayed, S Abhyankar, S Ericson, P Holman, C Keir, GD Myers	09/01/2017
Improved survival after acute graft-versus-host disease diagnosis in the modern era. Haematologica	HJ Khoury, T Wang, MT Hemmer, D Couriel, A Alousi, C Cutler, M Aljurf, JH Antin, M Ayas, M Battiwalla, JY Cahn, M Cairo, YB Chen, RP Gale, S Hashmi, RJ Hayashi, M Jagasia, M Juckett, RT Kamble, M Kharfan-Dabaja, M Litzow, N Majhail, A Miller, T Nishihori, M Qayed, H Schoemans, HC Schouten, G Socie, J Storek, L Verdonck, R Vij, WA Wood, L Yu, R Martino, M Carabasi, C Dandoy, U Gergis, P Hematti, M Solh, K Jamani, L Lehmann, B Savani, KR Schultz, BM Wirk, S Spellman, M Arora, J Pidala	05/01/2017
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. JCI insight	MJ Hartwell, U Özbek, E Holler, AS Renteria, H Major-Monfried, P Reddy, M Aziz, WJ Hogan, F Ayuk, YA Efebera, EO Hexner, U Bunworasate, M Qayed, R Ordemann, M Wölfl, S Mielke, A Pawarode, YB Chen, S Devine, AC Harris, M Jagasia, CL Kitko, MR Litzow, N Kröger, F Locatelli, G Morales, R Nakamura, R Reshef, W Rösler, D Weber, K Wudhikarn, GA Yanik, JE Levine, JL Ferrara	02/09/2017
African American Race Is a Newly Identified Risk Factor for Postengraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	H Sano, JA Hilinski, K Applegate, KY Chiang, A Haight, M Qayed, J Horan	02/01/2017
Prolonged Isotretinoin in Ultra High-Risk Neuroblastoma. Journal of pediatric hematology/oncology	T Cash, A Alazraki, M Qayed, HM Katzenstein	01/01/2017
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy. Cancer chemotherapy and pharmacology	A Marachelian, A Desai, F Balis, H Katzenstein, M Qayed, M Armstrong, KA Neville, SL Cohn, M Bush, R Gunawan, AP Lim, MA Smith, LM Smith	02/01/2016
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	AC Harris, R Young, S Devine, WJ Hogan, F Ayuk, U Bunworasate, C Chanswangphuwana, YA Efebera, E Holler, M Litzow, R Ordemann, M Qayed, AS Renteria, R Reshef, M Wölfl, YB Chen, S Goldstein, M Jagasia, F Locatelli, S Mielke, D Porter, T Schechter, Z Shekhovtsova, JL Ferrara, JE Levine	01/01/2016
Clinically significant adverse events after major ABO mismatch BMT. Bone marrow transplantation	RS Nickel, EK Waller, M Qayed, KY Chiang	01/01/2016
Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	EO Stenger, KY Chiang, A Haight, M Qayed, L Kean, J Horan	10/01/2015
Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	PA Mehta, MJ Zhang, M Eapen, W He, A Seber, B Gibson, BM Camitta, CL Kitko, CC Dvorak, ER Nemecek, HA Frangoul, H Abdel-Azim, KA Kasow, L Lehmann, M Gonzalez Vicent, MA Diaz Pérez, M Ayas, M Qayed, PA Carpenter, S Jodele, TC Lund, WH Leung, SM Davies	07/01/2015
CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. Blood	Y Suessmuth, R Mukherjee, B Watkins, DT Koura, K Finstermeier, C Desmarais, L Stempora, JT Horan, A Langston, M Qayed, HJ Khoury, A Grizzle, JA Cheeseman, JA Conger, J Robertson, A Garrett, AD Kirk, EK Waller, BR Blazar, AK Mehta, HS Robins, LS Kean	06/18/2015
Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	IB Copland, M Qayed, MA Garcia, J Galipeau, EK Waller	05/01/2015
Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 Neuroblastoma. Journal of pediatric hematology/oncology	S Kandula, RS Prabhu, R Nanda, JM Switchenko, T Cash, M Qayed, H Katzenstein, N Esiashvili	04/01/2015
Comparison of survival at adult versus pediatric treatment centers for rare pediatric tumors in an adolescent and young adult (AYA) population in the State of Georgia. Pediatric blood & cancer	T Cash, M Qayed, KC Ward, AC Mertens, L Rapkin	03/01/2015
Risk for CMV reactivation in children undergoing allogeneic hematopoietic stem cell transplantation. Pediatric blood & cancer	M Qayed, M Khurana, J Hilinski, S Gillespie, C McCracken, K Applegate, KY Chiang, J Horan	02/01/2015
The Role of Intestinal Microbiota in Graft versus Host Disease. Mini reviews in medicinal chemistry	M Qayed, JT Horan	01/01/2015
Atypical Marginal Zone Hyperplasia Is a Mimic for Lymphoma in Pediatric Transplant Recipients: Report of Two Patients. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society	SA Caltharp, M Qayed, SI Park	01/01/2015
Relative defects in mucosal immunity predict acute graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	KJ August, KY Chiang, M Qayed, A Dulson, D Worthington-White, CR Cole, JT Horan	07/01/2014
Treatment of hepatoblastoma with high-dose chemotherapy and stem cell rescue: the pediatric blood and marrow transplant consortium experience and review of the literature. Journal of pediatric hematology/oncology	EE Karski, CC Dvorak, W Leung, W Miller, PJ Shaw, M Qayed, E Katsanis, JH Feusner	07/01/2014
In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	DT Koura, JT Horan, AA Langston, M Qayed, A Mehta, HJ Khoury, RD Harvey, Y Suessmuth, C Couture, J Carr, A Grizzle, HR Johnson, JA Cheeseman, JA Conger, J Robertson, L Stempora, BE Johnson, A Garrett, AD Kirk, CP Larsen, EK Waller, LS Kean	11/01/2013
Dose-intensive cisplatin for hepatoblastoma: have you heard? The Lancet. Oncology	M Qayed, HM Katzenstein	08/01/2013
Rifaximin for preventing acute graft-versus-host disease: impact on plasma markers of inflammation and T-cell activation. Journal of pediatric hematology/oncology	M Qayed, A Langston, KY Chiang, K August, JA Hilinski, CR Cole, A Rogatko, RM Bostick, JT Horan	05/01/2013
Ewing sarcoma with 7;22 translocation: three new cases and clinicopathological characterization. Fetal and pediatric pathology	SC Shulman, H Katzenstein, J Bridge, LL Bannister, M Qayed, S Oskouei, BM Shehata	12/01/2012
Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas. Pediatric blood & cancer	L Rapkin, M Qayed, P Brill, M Martin, D Clark, BA George, TA Olson, K Wasilewski-Masker, A Alazraki, HM Katzenstein	11/01/2012
Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma. Pediatric blood & cancer	M Qayed, KY Chiang, R Ricketts, A Alazraki, A Tahvildari, A Haight, B George, N Esiashvili, HM Katzenstein	03/01/2012
Is the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation? Pediatric blood & cancer	M Qayed, A Thompson, K Applegate, A Haight, A Rogatko, KY Chiang, J Horan	07/15/2010
Irinotecan as maintenance therapy in high-risk hepatoblastoma. Pediatric blood & cancer	M Qayed, C Powell, ER Morgan, M Haugen, HM Katzenstein	05/01/2010
Hypercalcemia in pediatric acute megakaryocytic leukemia: case report and review of the literature. Journal of pediatric hematology/oncology	M Qayed, I Ahmed, RP Valentini, B Cushing, M Rajpurkar	05/01/2009